Endeavour Silver (EXK) Earnings Analysis
Endeavour Silver (EXK) next reports earnings on 2026-07-29, consensus EPS 0.1783 USD. Last quarter (2026-02-27) it missed with EPS 0.02 USD vs 0.03 USD est (-33.3%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -130.11.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EXK next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 0.1783 USD |
| Revenue estimate | 0.21B |
EXK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-27 | 0.02 USD | 0.03 USD | -33.3% | Miss |
| 2025-11-07 | -0.01 USD | 0.0275 USD | -136.4% | Miss |
| 2025-08-13 | -0.03 USD | 0.01 USD | -400% | Miss |
| 2025-03-11 | 0.02 USD | -0.01 USD | +300% | Beat |
| 2024-08-01 | -0.06 USD | -0.012 USD | -400% | Miss |
Beat rate: 1/5 (20%) over reported quarters with consensus data.
EXK valuation and analyst view
| Trailing P/E | -130.11 |
|---|---|
| Trailing EPS | -0.07487 USD |
| Price / book | 3.66 |
| Dividend yield | 0.00% |
| Market cap | 2.48B |
| Analyst consensus | Buy (11 buy / 2 hold / 1 sell) |
| Avg price target | 11.56 USD |
Related research pages
Frequently asked questions
When is Endeavour Silver (EXK)'s next earnings date?
Endeavour Silver is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.1783 USD and revenue estimate of 0.21B.
Did EXK beat earnings last quarter?
In its 2026-02-27 report, EXK posted EPS of 0.02 USD versus a 0.03 USD estimate — a miss of 33.3%.
What is EXK's earnings track record?
Over the last 5 reported quarters with consensus data, EXK beat estimates 1 times (20%).
What is EXK's current P/E ratio and EPS?
EXK trades at a trailing P/E of -130.11 on trailing EPS of -0.07486781381809961 USD.
What do analysts rate EXK?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 11 buy, 2 hold, 1 sell, 0 strong sell). Average 12-month price target: 11.56 USD.